During the past decade, Spitalul Clinic Judetean de Urgenta Brasov conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 15 clinical trials were completed, i.e. on average, 214.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spitalul Clinic Judetean de Urgenta Brasov" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Gilead Sciences" with 3 trials sponsored, "AOP Orphan Pharmaceuticals AG" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Ferring Pharmaceuticals" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spitalul Clinic Judetean de Urgenta Brasov" #1 collaborator was "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Chiesi USA, Inc." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "PharmaEssentia (Co-Sponsor for USA)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Spitalul Clinic Judetean de Urgenta Brasov" are "Chronic Lymphocytic Leukemia" (3 trials), "Atrial Fibrillation" (2 trials), "Non-Hodgkin's Lymphoma" (2 trials), "Polycythemia Vera" (2 trials) and "Prostate Cancer" (2 trials). Many other conditions were trialed in "Spitalul Clinic Judetean de Urgenta Brasov" in a lesser frequency.

Most popular intervention types in "Spitalul Clinic Judetean de Urgenta Brasov" are "Drug" (18 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bendamustine" (3 trials), "Idelalisib" (3 trials), "Placebo" (3 trials), "Rituximab" (3 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Spitalul Clinic Judetean de Urgenta Brasov" are 18 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Spitalul Clinic Judetean de Urgenta Brasov". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Spitalul Clinic Judetean de Urgenta Brasov, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Spitalul Clinic Judetean de Urgenta Brasov, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".